(CRVL) CorVel - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2210061097

CRVL: Workers Compensation, Claims Management, Medical Billing, Care Management

CorVel Corporation specializes in providing comprehensive risk management solutions, focusing on workers compensation, auto, liability, and health services. Leveraging advanced technologies such as artificial intelligence, machine learning, and natural language processing, the company enhances care episode management and cost containment through predictive analytics and process automation. Their network solutions include automated medical fee auditing and reimbursement management, optimizing provider networks and ensuring compliance with treatment guidelines. Patient management services encompass case management, utilization review, and vocational rehabilitation, streamlining claims processing for self-insured entities. Serving employers, third-party administrators, insurers, and government agencies, CorVel aims to reduce medical costs while maintaining care quality. Established in 1987, the company operates from Fort Worth, Texas.

Over the next three months, CorVels stock is expected to consolidate near its SMA 50 level of 110.93, with potential support at the SMA 200 level of 108.93. The high P/E ratio of 68.10 indicates market expectations for growth, while the elevated P/B of 19.65 reflects confidence in the companys asset value. The strong RoE of 21.88% underscores efficient equity use, supporting sustained valuations. However, the high P/S ratio of 6.78 suggests caution. The stock may face resistance at its SMA 20 of 112.95, with possible pullback due to profit-taking, testing support levels if market sentiment shifts.

Additional Sources for CRVL Stock

CRVL Stock Overview

Market Cap in USD 5,754m
Sector Financial Services
Industry Insurance Brokers
GiC Sub-Industry Health Care Services
IPO / Inception 1991-06-28

CRVL Stock Ratings

Growth Rating 93.7
Fundamental 54.4
Dividend Rating 0.0
Rel. Strength 8.36
Analysts -
Fair Price Momentum 138.20 USD
Fair Price DCF 23.78 USD

CRVL Dividends

No Dividends Paid

CRVL Growth Ratios

Growth Correlation 3m 4.3%
Growth Correlation 12m 76.6%
Growth Correlation 5y 94.1%
CAGR 5y 45.62%
CAGR/Max DD 5y 1.23
Sharpe Ratio 12m 0.50
Alpha 22.51
Beta 0.925
Volatility 29.13%
Current Volume 111.3k
Average Volume 20d 134.2k
What is the price of CRVL stocks?
As of May 09, 2025, the stock is trading at USD 112.22 with a total of 111,300 shares traded.
Over the past week, the price has changed by +2.98%, over one month by +4.24%, over three months by -4.40% and over the past year by +32.67%.
Is CorVel a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, CorVel (NASDAQ:CRVL) is currently (May 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 54.42 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CRVL as of May 2025 is 138.20. This means that CRVL is currently undervalued and has a potential upside of +23.15% (Margin of Safety).
Is CRVL a buy, sell or hold?
CorVel has no consensus analysts rating.
What are the forecast for CRVL stock price target?
According to ValueRays Forecast Model, CRVL CorVel will be worth about 156.3 in May 2026. The stock is currently trading at 112.22. This means that the stock has a potential upside of +39.24%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 156.3 39.2%